We are live on ! Find out more
SIG

Sargent Investment Group Portfolio holdings

AUM $759M
1-Year Est. Return 28.58%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+28.58%
3 Year Est. Return
+104.74%
5 Year Est. Return
+107.13%
10 Year Est. Return
–
AUM
$557M
AUM Growth
+$66.4M
Cap. Flow
+$23.2M
Cap. Flow %
4.17%
Top 10 Hldgs %
40.34%
Holding
228
New
8
Increased
98
Reduced
74
Closed
12

Top Buys

Rank Stock Value
1
SPYV icon
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
+$6.87M
2
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$6.26M
3
BILS icon
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
+$6.16M
4
FTCS icon
First Trust Capital Strength ETF
FTCS
+$2.05M
5
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.03M

Top Sells

Rank Stock Value
1
FTGC icon
First Trust Global Tactical Commodity Strategy Fund
FTGC
+$2.21M
2
XRX icon
Xerox
XRX
+$1.61M
3
UITB icon
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
+$1.26M
4
FDN icon
First Trust Dow Jones Internet Index Fund ETF
FDN
+$581K
5
PLTR icon
Palantir
PLTR
+$423K

Sector Composition

Rank Sector Weight
1 Technology 25.07%
2 Financials 11.45%
3 Healthcare 9.8%
4 Industrials 6.53%
5 Real Estate 4.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTI icon
201
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$212K 0.04%
750
-110
-13% -$30K
NVO
202
Novo Nordisk
NVO
$209B
$211K 0.04%
1,776
– –
IBB icon
203
iShares Biotechnology ETF
IBB
$9.76B
$211K 0.04%
+1,449
New +$210K
PYPL icon
204
PayPal
PYPL
$50.4B
$204K 0.04%
+2,620
New +$175K
RIG icon
205
Transocean
RIG
$5.84B
$163K 0.03%
38,370
-29,760
-44% -$147K
JYNT icon
206
The Joint Corp
JYNT
$121M
$122K 0.02%
10,680
– –
AKTS
207
DELISTED
Akoustis Technologies Inc
AKTS
$96.1K 0.02%
1,073,800
+160,000
+18% +$15.4K
RLMD icon
208
Relmada Therapeutics
RLMD
$521M
$69.5K 0.01%
21,460
– –
RVNC
209
DELISTED
Revance Therapeutics, Inc.
RVNC
$66.1K 0.01%
12,732
-115
-0.9% -$572
CHRS icon
210
Coherus Oncology
CHRS
$196M
$44.9K 0.01%
43,130
– –
OPTT icon
211
Ocean Power Technologies
OPTT
$50.1M
$31.2K 0.01%
+200,000
New +$49.4K
BLUE
212
DELISTED
bluebird bio
BLUE
$20K ﹤0.01%
1,926
– –
ASRT
213
DELISTED
Assertio
ASRT
$18.1K ﹤0.01%
1,021
-42
-4% -$833
OM icon
214
Outset Medical
OM
$89.5M
$17.5K ﹤0.01%
1,720
– –
TELL
215
DELISTED
Tellurian Inc.
TELL
$14.5K ﹤0.01%
15,000
– –
LONA
216
LeonaBio Inc
LONA
$72.3M
$8.7K ﹤0.01%
1,952
– –
BA icon
217
Boeing
BA
$186B
– –
-1,189
Closed -$216K
DNA icon
218
Ginkgo Bioworks
DNA
$514M
– –
-2,759
Closed -$36.9K
DOX icon
219
Amdocs
DOX
$6.24B
– –
-3,659
Closed -$289K
FOF icon
220
Cohen & Steers Closed End Opportunity Fund
FOF
$379M
– –
-15,085
Closed -$180K
CBIO
221
Crescent Biopharma
CBIO
$624M
– –
-1,000
Closed -$28.2K
INTC icon
222
Intel
INTC
$510B
– –
-8,750
Closed -$271K
JPIE icon
223
JPMorgan Income ETF
JPIE
$10.2B
– –
-7,259
Closed -$330K
JSCP icon
224
JPMorgan Short Duration Core Plus ETF
JSCP
$1.71B
– –
-5,865
Closed -$272K
SCHW
225
Charles Schwab
SCHW
$187B
– –
-3,530
Closed -$260K
6 7 8
9
10

Similar funds

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
TVAMP
Tennessee Valley Asset Management Partners Knoxville, Tennessee $757M AUM 14.19% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
GWM
Gibbs Wealth Management Alpharetta, Georgia $762M AUM 18.55% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
JGUA
John G. Ullman & Associates Corning, New York $754M AUM 60.05% 1-Year Est. Return
HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return

Sargent Investment Group's Q3 2024 Portfolio in Review

As of Q3 2024, Sargent Investment Group held 228 positions worth $557M, up 14% from $490M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sargent Investment Group deployed $23.2M of net new capital in Q3 2024, opening 8 new positions and adding to 98 existing holdings. Its largest new stake was Bristol-Myers Squibb: 9,269 shares worth $480K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was First Trust Global Tactical Commodity Strategy Fund, an estimated $2.21M trimmed.

  • Sargent Investment Group's largest Q3 2024 buy was Bristol-Myers Squibb: 9,269 shares worth $480K.
  • Sargent Investment Group added most to State Street SPDR Portfolio S&P 500 Value ETF in Q3 2024, an estimated $6.87M increase.
  • Sargent Investment Group's biggest Q3 2024 reduction was First Trust Global Tactical Commodity Strategy Fund, cutting an estimated $2.21M.
  • Sargent Investment Group fully exited Xerox in Q3 2024, selling an estimated $1.61M.
  • Sargent Investment Group's ten largest holdings make up 40% of its $557M portfolio in Q3 2024.
  • Sargent Investment Group opened 8 new positions and closed 12 in Q3 2024.
  • Sargent Investment Group's portfolio value rose 14% quarter-over-quarter to $557M.

Based on Sargent Investment Group's 13F filing for Q3 2024, filed 6 Nov 2024.